Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Rosiglitazone Stories

2013-05-09 23:43:35

Alert: Granuflo Allegedly Linked to Serious Health Risks Including Stroke, Heart Attack and Cardiopulmonary Arrest. Dallas, TX (PRWEB) May 08, 2013 The National Plaintiff´s Law Firm of Baron and Budd is now handling lawsuits pertaining to the recall of Granuflo, the brand name of a dialysate (http://www.fda.gov/medicaldevices/safety/listofrecalls/ucm309990.htm ). Dialysate is used when a patient undergoes dialysis, a long-term medical treatment used to treat kidney conditions....

2013-05-07 08:27:42

ST. PAUL, Minn., May 7, 2013 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), announced today that it has been awarded two Honorable Mentions in the 2012 Award for Excellence from the Journal of Managed Care Pharmacy (JMCP). One study examined the impact of generic drug discount programs on levothyroxine (a drug to treat low thyroid) pharmacy claims data. A second study reviewed members' medication use following the implementation of a rosiglitazone (a...

2013-04-23 22:38:17

Epoxide hydrolase inhibition and thiazolidinediones Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the...

2013-04-19 23:01:41

The Law Offices of Berman and Berman have just announced that they are taking new Avandia lawsuit and compensation cases. They have successfully worked many cases for the generic drug Rosiglitazone, which goes by the brand name Avandia. New York, NY (PRWEB) April 19, 2013 The Berman Law Group are extending their legal efforts in fighting for justice for all people who have been potentially hurt by the drug Avandia. They are now taking new cases and are able to fight and potentially win...

FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June
2013-04-14 07:29:51

redOrbit Staff & Wire Reports — Your Universe Online Three years after restricting sales of Avandia, the US Food and Drug Administration (FDA) has scheduled a health advisory panel to re-evaluate the safety of the diabetes drug, various media outlets reported on Friday. The FDA limited the availability of the pill to patients who could not control their diabetes with any other medication due to an increased risk of heart attack and death associated with the product, according...

2013-03-05 23:04:11

The law firm of d´Oliveira & Associates has issued a new infographic about the type-2 diabetes drug, Actos, and potential dangers the drug may pose. (PRWEB) March 05, 2013 Manufactured by the Japanese pharmaceutical company Takeda, Actos (pioglitazone) is a type-2 diabetes drug used to control glucose levels in patients over the age of 18 years. The FDA drug safety information on Actos lists possible side effects that include nausea, hypoglycemia, broken bones, eye problems, and...

Diabetes Drug Boosts Memory
2012-11-21 20:50:57

Brett Smith for redOrbit.com — Your Universe Online A controversial drug may have a new lease on life as researchers at the University of Texas Medical Branch at Galveston have found it could have unintended benefits for people with Alzheimer´s disease. The anti-insulin-resistance drug rosiglitazone, marketed by Glaxo-Smith Kline as Avandia, has been shown to enhance learning and memory in mice that have been genetically engineered to serve as models for Alzheimer's...

2012-10-05 23:00:23

Wright & McGurk is warning consumers of a recent study which links popular Type- 2 diabetes drug Actos with increased risk of bladder cancer. (PRWEB) October 05, 2012 A popular class of type 2 diabetes medication increases patients´ risk of bladder cancer, according to a new study published in the Journal of the National Cancer Institute. Researchers at the Perelman School of Medicine at the University of Pennsylvania found that patients taking thiazolidinedione (TZDs) drugs such...

2012-08-20 23:03:03

Parker Waichman LLP is informing the public that generic versions of Actos (pioglitazone), which were recently approved, carry the same risks and side effects as the brand name medication. Actos is a Type 2 diabetes drug that has been repeatedly linked to bladder cancer, most recently in a study published in the Journal of the National Cancer Institute. (PRWEB) August 20, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs,...

2012-08-17 23:01:41

How safe are diabetes drugs? The $3 billion fine and felony guilty plea in July 2012 by the maker of Avandia, and the whistleblower lawsuit pending against the maker of Actos, raise serious safety concerns for people with diabetes, writes attorney and consumer advocate Michael J. Evans in Part 1 of a series published on ConsumerNews.com. Birmingham, AL (PRWEB) August 17, 2012 Last month the maker of Avandia, GlaxoSmithKline ("GSK") agreed with the U.S. Department of Justice to pay a $3...